Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$845,346,245
+$16,015,020 QoQ
Shares Held
6,578,570
-4.6% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
#43
of 3,769 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aristotle Capital Management, LLC holds $2,001,472,111 across 6 Drug Manufacturers - General names. MRK ranks #2 (42.2% of the industry book) .
All Filings in MRK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $845,346,245 | 6,578,570 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $829,331,225 | 6,894,432 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $766,386,797 | 7,280,893 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $656,159,536 | 7,817,938 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $644,010,296 | 8,135,552 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $759,706,110 | 8,463,749 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $864,315,366 | 8,688,333 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,013,060,697 | 8,920,929 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,106,851,479 | 8,940,642 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,213,263,228 | 9,194,871 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,034,309,588 | 9,487,338 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,021,634,620 | 9,923,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,172,203,392 | 10,158,622 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,097,697,124 | 10,317,672 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,155,825,175 | 10,417,532 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $764,566,987 | 8,877,926 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||